Here are relevant reports on : molecular-diagnostics-market
-
Epigenetic Drugs & Diagnostics Market - Global Forecast to 2030
Epigenetic Drugs & Diagnostics Market
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Companion Diagnostics Market - 2019 By Types, Application & Geography
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Plant Genomics Market by Objective (Extraction, Sequencing, Genotyping, Gene Expression, MAS, and GMO-trait Purity Testing), Type (Molecular Engineering and Genetic Engineering), Trait, Application, and Region - Global Forecast 2025
The Plant Genomics Market is expected to grow from USD 7.3 billion in 2019 to USD 11.7 billion by 2025, at a CAGR of 8.3% during the forecast period. This report includes a study on the marketing and development strategies, along with a study on the product portfolios of the leading companies operating in the plant genomics market. It includes the profiles of leading companies such as Eurofins Scientific (Luxembourg), Illumina, Inc. (US), NRGene (Israel), Neogen Corporation (US), Qiagen (Germany), Agilent Technologies (US), KeyGene (Netherlands), LC Sciences (US), Traitgenetics GmbH (Germany), Novogene Corporation (China), Oxford Nanopore Technologies (UK), Genewiz (US), BGI Genomics (China), Genotypic Technologies (India), and Floragenex (US).
- Published: August 2019
- Price: $ 4950
- TOC Available:
-
Ligase Enzymes Market by Type (DNA, RNA), Source (Viral, Bacterial, Eukaryotic), Grade (RUO, GMP, Diagnostic), Molecular Biology Workflow (Cloning, Sequencing, Synthetic Biology), Application (Research, Diagnostic, Therapeutic) - Global Forecast 2030
The global ligase enzymes market, valued at US$0.25 billion in 2024, stood at US$0.26 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$0.36 billion by the end of the period. The ligase enzymes market is growing due to the rising demand for molecular diagnostics, the increasing adoption of next-generation sequencing (NGS), expanding applications in synthetic biology, and continuous advancements in enzyme engineering.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Meat Speciation Testing Market by Species (Bos Taurus, Sus Scrofa, Gallus Gallus, Equus Caballus, Ovis Aries), Technology (PCR, ELISA, Molecular Diagnostic), Form (Raw, Cooked, Processed), and Region - Global Forecast to 2022
The meat speciation testing market is projected to grow at a CAGR of 8.20% from 2016 to 2022, to reach a projected value of USD 2,220.6 Million by 2022. The market is driven by increase in number of adulteration and food fraud cases, religious beliefs, and compliance with labeling laws, and stringent regulations and consumer demand for certified products.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Chemoinformatics Market by Application (Chemical Analysis (Chemical Databases, Chemo Metrics, Molecular Modelling), Drug Discovery (High Throughput Screening, Lead Identification and Optimization, QSAR/QSPR), Drug Validation) - Global Forecast to 2023
Growth of the chemoinformatics market is primarily driven by innovations and advancements in the drug development process, advances in the computer technology, increased demand of personalized medicine. On the other hand, cost associated with the chemoinformatics software is one of the major factors restraining the growth of this market. Whereas emerging markets are expected to provide significant growth opportunities in this market.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Nanosensors Market - By Application, Technology (Carbon nanotube, Nanowires) ,TYPES (Gas/Liquid, Bio-molecular), & Geography - Analysis & Forecast (2014-2020)
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Molecular Breeding Market by Process (QTL Mapping, Marker-Assisted Selection, Marker-Assisted Backcrossing, and Genomic Selection), Marker (SNP, SSR), Application (Crop Breeding and Livestock Breeding), and Region-Global Forecast to 2023
The molecular breeding market is estimated at USD 1.79 billion in 2018 and is projected to reach USD 3.95 billion by 2023, at a CAGR of 17.11% during the forecast period. The agricultural benefits associated with these adjuvant solutions are the major factors contributing to the growth of this market, globally. The growth of economies in developing countries, coupled with the increasing R&D expenses in the agriculture industry drives the growth potential of these markets.The global market for molecular breeding is dominated by key players such as Eurofins (Luxembourg), Illumina (US), LGC Limited (UK), Thermo Fisher Scientific (US), and SGS (Switzerland). Some emerging players in the molecular breeding market include DanBred (Denmark), Intertek Group (UK), LemnaTec (Germany), Charles River (US), Slipstream Automation (New Zealand), and Fruitbreedomics (consortium).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Antimicrobial Susceptibility Testing Market by Product (Manual (Disk, Strip, Plate), Automated, Molecular), Method (e-test, Disk & Agar Diffusion, Genotypic), Type (Antibacterial, Antifungal), Application (Clinical, Epidemiology) Global Forecasts to 2029
The global antimicrobial susceptibility testing market, valued at US$4.28 billion in 2023, stood at US$4.45 billion in 2024 and is projected to advance at a resilient CAGR of 5.0% from 2024 to 2029, culminating in a forecasted valuation of US$5.68 billion by the end of the period. Major driving factors for market growth include the increasing prevalence of antibiotic-resistant infections and a greater demand for effective treatments.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Targeted Protein Degradation Market by Type [PROTACs (Vepdegestrant, Bavdegalutamide), SERDs (Elacestrant), Molecular Glues (Mezigdomide), LDD, LYTAC/ATAC], Indication (Oncology, Inflammatory), Formulation (Oral), End User - Global Forecast to 2035
The global targeted protein degradation market, valued at US$0.01 billion in 2024, stood at US$0.48 billion in 2025 and is projected to advance at a resilient CAGR of 35.4% from 2025 to 2035, culminating in a forecasted valuation of US$9.85 billion by the end of the period. The Asia Pacific market is projected to grow at a significant CAGR during the forecast period, owing to increasing research & development activities for novel degraders.
- Published: August 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
